Clene (CLNN) Price to Book (2019 - 2026)
Clene (CLNN) posted Price to Book of 3.18 for Q2 2026, up 12.25% on a QoQ basis from 3.62 in Q4 2025, and up 26.58% year-over-year from 2.51 in Q2 2025.
Analysis
Clene (CLNN) Price to Book (2019 - 2026) Analysis & Trends
Clene has reported Price to Book for 8 years, with the latest figure at 3.18 in Q2 2026.
- On a quarterly basis, Price to Book rose 26.58% year-over-year to 3.18 in Q2 2026; TTM through Jun 2026 was 3.18, a 26.58% increase from a year earlier, with the FY2025 full-year figure at 3.62, up 25.35% from the prior year.
- Price to Book was 3.18 for Q2 2026 at Clene, up from 3.62 in the prior quarter.
- The five-year high for Price to Book was 123.55 in Q1 2022, with the low at 283.88 in Q2 2022.
- Average Price to Book over 5 years is 18.5, with a median of 4.33 recorded in 2025.
- The sharpest annual moves came in 2022 and 2024: Price to Book soared 685.4% in 2022, then sank 2712.8% in 2024.
- Over 5 years, Price to Book stood at 23.1 in 2022, then plunged by 89.82% to 2.35 in 2023, then slumped by 306.28% to 4.85 in 2024, then gained by 25.35% to 3.62 in 2025, then increased by 12.25% to 3.18 in 2026.
- The last three Price to Book figures came in at 3.18 (Q2 2026), 3.62 (Q4 2025), and 4.99 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn |
| 10 | Clene | 45.69 Mn | 45.69 Mn | 54,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.18 |
| Dec 31, 2025 | -3.62 |
| Sep 30, 2025 | -4.99 |
| Jun 30, 2025 | -4.33 |
| Mar 31, 2025 | -5.37 |
| Dec 31, 2024 | -4.85 |
| Sep 30, 2024 | -7.63 |
| Jun 30, 2024 | -91.91 |
| Mar 31, 2024 | 12.95 |
| Dec 31, 2023 | 2.35 |
| Sep 30, 2023 | 3.00 |
| Jun 30, 2023 | 3.52 |
| Mar 31, 2023 | -54.13 |
| Dec 31, 2022 | 23.10 |
| Sep 30, 2022 | -19.09 |
| Jun 30, 2022 | -283.88 |
| Mar 31, 2022 | 123.55 |
| Dec 31, 2021 | 20.28 |
| Sep 30, 2021 | 74.69 |
| Jun 30, 2021 | -26.31 |